Systematic Reviews of Treatments for Hepatitis B


Follow the links below to find summaries of systematic reviews of the evidence for the effectiveness of treatments for Hepatitis B.

Reviewed January 2009

Printer friendly page

9 Resources Found
Results 1 to 9 displayed.

Title:   Combined DTP-HBV-HIB vaccine versus separately administered DTP-HBV and HIB vaccines for primary prevention of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae B (HIB)
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Childhood vaccinations provide an effective method of protection against many diseases. There are multiple advantages to combining vaccines: reducing the number of visits, injections and patient discomfort, increasing compliance, and optimizing preventi...
Date:   Mar 2009

Title:   Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Several million people world-wide are infected with hepatitis B virus. The infection may cause serious short-term and long-term effects including portal hypertension, liver failure, liver cancer, and death. Hepatitis B vaccination is reported to be bene...
Date:   May 2008

Title:   Bicyclol for chronic hepatitis B
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Bicyclol is a novel synthetic 'anti-hepatitis' drug, used primarily in China for patients with chronic hepatitis B. No well-designed randomised clinical trials were found evaluating the benefits or possible harms of bicyclol for patients with chronic he...
Date:   Aug 2006

Title:   Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Interferon is an established treatment for chronic infection with hepatitis B virus. Although it is effective, response rates are not satisfactory. In order to increase response rates glucocorticosteroid withdrawal therapy has been proposed as a pretrea...
Date:   May 2005

Title:   Milk thistle for alcoholic and/or hepatitis B or C virus liver diseases
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Milk thistle (Silybum marianum (L) Gaertneri) extracts have been used as medical remedies since the time of ancient Greece. Alcohol and hepatotoxic viruses are the major causes of liver diseases. Several trials have studied the effects of milk thistle f...
Date:   Jan 2005

Title:   Hepatitis B vaccination for patients with chronic renal failure
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Patients with chronic renal failure are at increased risk of hepatitis B virus infections. This review was undertaken to determine the beneficial and harmful effects of vaccination against hepatitis B and of a reinforced recombinant vaccination series. ...
Date:   May 2004

Title:   Alpha-fetoprotein and/or liver ultrasonography for liver cancer screening in patients with chronic hepatitis B
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   There is inadequate evidence to decide whether screening for liver cancer with alpha-fetoprotein and/or ultrasound of the liver compared to no screening is beneficial to patients infected with the hepatitis B virus. Only two randomised trials could be i...
Date:   Nov 2002

Title:   Chinese medicinal herbs for asymptomatic carriers of hepatitis B virus infection
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Chinese medicinal herbs have a long history in the treatment of liver diseases. Three randomised clinical trials were included. Due to their poor methodologic quality and the existing small number of trials, there is currently insufficient evidence for ...
Date:   Feb 2001

Title:   Chinese medicinal herbs for chronic hepatitis B
Publisher:   John Wiley and Sons, Ltd. for The Cochrane Collaboration
Description:   Chronic hepatitis B is an infectious disease of the liver caused by hepatitis B virus. Around 350 million people worldwide are chronic infected carriers of the virus. Traditional Chinese medicinal herbs have for long been used for treating chronic liver...
Date:   Oct 2000
Results 1 to 9 displayed.
  • Other Related Topics: